Reports
Sale
Global Infection Surveillance Solutions Market Size, Share: By Product and Services: Product, Services; By Infection Type: Surgical Site Infection, Urinary Tract Infection, Blood Stream Infection, Others; By End User: Hospitals and Clinics, Ambulatory Surgical Centers, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Infection Surveillance Solutions Market Outlook
The global infection surveillance solutions market size reached a value of around USD 612.12 million in 2023, driven by increasing prevalence of infectious diseases. The market is expected to grow at a CAGR of 14.0% during the forecast period of 2024-2032, likely to attain a value of around USD 1992.15 million by 2032.
Infection Surveillance Solutions: Introduction
Infections or infectious diseases are the illnesses in humans or animals due to the presence and growth of the pathogens. To prevent the outbreak of these infectious diseases, we need appropriate surveillance solutions. Surveillance of infections means collection of data, analysing the data and deriving inferences, and providing solutions/ measures to prevent the spread of the disease.
Infection surveillance solutions include the following systems and tools: Electronic health records (EHRs), syndromic surveillance systems, laboratory information management systems (LIMS), outbreak management systems, data analytics and visualization tools, global surveillance networks and notifiable disease reporting systems.
Global Infection Surveillance Solutions Market Analysis
Based on segments, the market is divided into product and services, infection type, end users, and region.
Market Breakup by Product and Services
- Product
- Software
- Web/Cloud Based
- On-premises Based
- Software
- Services
- Product Support and Maintenance Services
- Training and Consulting Services
- Implementation Services
- Other Services
Market Breakup by Infection Type
- Surgical Site Infection
- Urinary Tract Infection
- Blood Stream Infection
- Others
Infection Surveillance Solutions Market Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Specialty Centres
- Long-term Care Facilities
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Infection Surveillance Solutions Market Scenario
The growth of the market is driven by the increasing prevalence of infectious diseases. During the transmission of an infection, there is a requirement to maintain and curb the spread of the infections, that helps fuelling the growth of this market. In order to prevent the outbreak of infections and virus, like coronavirus, we need infection surveillance solutions in place, so that calculated steps can be taken to prevent the spread of infections.
Rapid advances in technology, data analytics tools, real time monitoring, and predictive tools have led to the development of infection surveillance solutions market. Increasing adoption of Electronic Health Records by the healthcare systems have led to the direct linkup of the patient data with the surveillance systems, that can help in easy trace back of the patient with possible symptoms of the infection which can be very beneficial is curbing the spread of the infection.
Infection Surveillance Solutions Market: Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global infection surveillance solutions market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Becton, Dickinson and Company
- Baxter International Inc.
- Wolters Kluwer NV
- Premier Inc.
- Gojo Industries
- BioVigil Healthcare Systems Inc.
- Medexter Healthcare GmbH
- Koninklijke Philips NV
- PeraHealth
- Deb Group Ltd.
- Cerner Corporation
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Infection Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Infection Surveillance Solutions Market Overview
3.1 Global Infection Surveillance Solutions Market Historical Value (2017-2023)
3.2 Global Infection Surveillance Solutions Market Forecast Value (2024-2032)
4 Global Infection Surveillance Solutions Market Landscape
4.1 Global Infection Surveillance Solutions Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Infection Surveillance Solutions Product Landscape
4.2.1 Analysis by Product and Services
4.2.2 Analysis by Infection Type
5 Global Infection Surveillance Solutions Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Infection Surveillance Solutions Market Segmentation
6.1 Global Infection Surveillance Solutions Market by Product and Services
6.1.1 Market Overview
6.1.2 Product
6.1.2.1 Software
6.1.2.1.1 Web/Cloud Based
6.1.2.1.2 On-premises Based
6.1.3 Services
6.1.3.1 Product Support and Maintenance Services
6.1.3.2 Training and Consulting Services
6.1.3.3 Implementation Services
6.1.3.4 Other Services
6.2 Global Infection Surveillance Solutions Market by Infection Type
6.2.1 Market Overview
6.2.2 Surgical Site Infection
6.2.3 Urinary Tract Infection
6.2.4 Blood Stream Infection
6.2.5 Others
6.3 Global Infection Surveillance Solutions Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Ambulatory Surgical Centers
6.3.4 Specialty Centers
6.3.5 Long-term Care Facilities
6.3.6 Others
6.4 Global Infection Surveillance Solutions Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Infection Surveillance Solutions Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Infection Surveillance Solutions Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Infection Surveillance Solutions Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Infection Surveillance Solutions Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Infection Surveillance Solutions Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Becton, Dickinson and Company
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Baxter International Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Wolters Kluwer NV
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Premier Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Gojo Industries
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 BioVigil Healthcare Systems Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Medexter Healthcare GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Koninklijke Philips NV
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 PeraHealth
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Deb Group Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Cerner Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
18 Global Infection Surveillance Solutions Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 612.12 million in 2023, driven by the increasing prevalence of infectious diseases, technological advances in healthcare technology, and focus on data driven healthcare decision making.
The market is anticipated to grow at a CAGR of 14% during the forecast period of 2024-2032 to attain a value of around USD 1992.15 million by 2032.
The growth of the market is driven by factors like the increasing prevalence of infectious diseases, technological advances in healthcare technology, emphasis on infection control and prevention, and focus on data driven healthcare decision making.
The key trends which are bolstering the market growth include integration with digital health technologies, data analysis and predictive decision making, and increasing adoption of real time surveillance.
The products in the market include software, which can further be categorised into web/cloud based and on-premises based. Services can be categorised into product support and maintenance services, training and consulting services, and implementation services, among others.
The infection types can be divided into surgical site infection, urinary tract infection, and blood stream infection, among others.
The end-users can be segmented into hospitals and clinics, ambulatory surgical centres, speciality centres, and long-term care facilities, among others.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players in the market can be categorised into Becton, Dickinson and Company, Baxter International Inc., Wolters Kluwer NV, Premier Inc., Gojo Industries, BioVigil Healthcare Systems Inc., Medexter Healthcare GmbH, Koninklijke Philips NV, PeraHealth, Deb Group Ltd., and Cerner Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER